INFLECTRA is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Infliximab.
Product ID | 0069-0809_11db24ec-e95d-4127-a1e8-fb3aa917317d |
NDC | 0069-0809 |
Product Type | Human Prescription Drug |
Proprietary Name | INFLECTRA |
Generic Name | Infliximab-dyyb |
Dosage Form | Injection, Powder, Lyophilized, For Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2016-11-21 |
Marketing Category | BLA / BLA |
Application Number | BLA125544 |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | INFLIXIMAB |
Active Ingredient Strength | 100 mg/10mL |
Pharm Classes | Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2016-11-21 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125544 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-11-21 |
Ingredient | Strength |
---|---|
INFLIXIMAB | 100 mg/10mL |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
INFLECTRA 97621433 not registered Live/Pending |
Inflectra Corporation 2022-10-06 |
INFLECTRA 85422792 not registered Dead/Abandoned |
Hospira, Inc. 2011-09-14 |
INFLECTRA 79152119 4766483 Live/Registered |
Pfizer Limited 2014-05-20 |
INFLECTRA 77335082 3457870 Live/Registered |
Inflectra Corporation 2007-11-21 |